摘要 |
The invention relates to methods to characterize exemplified compounds such as 3beta, 17beta-dihydroxyandrost-1,5,11 -triene and 3beta, 17beta-dihydroxy-17alpha-ethynylandrost-1,5,11-triene and to the use of described compounds to ameliorate or treat a condition such as thrombocytopenia, inflammation or other exemplified conditions.
|